Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 59,353
- Share change
- -1,093,042
- Total reported value
- $169,156
- Price per share
- $2.85
- Number of holders
- 1
- Value change
- -$3,224,887
- Number of buys
- 1
- Number of sells
- 1
Report period
Q3 2024
Institutions
1
Top holders
1
OCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Ownership snapshot
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BROADWOOD CAPITAL INC
13D/G signal
—
Evidence rows
35
Latest as of
30 Jun 2024
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
15%
|
$14,540,745
4,929,066 shares
|
— | 30 Jun 2024 |
| AWM Investment Company, Inc. |
13F
Company
|
3.9%
|
$3,236,666
1,097,175 shares
|
— | 30 Jun 2024 |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
10%+ Owner · Company
|
1.5%
from 13F
|
$3,044,309
16,591,052 shares
mixed-class rows
|
— | 14 Apr 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.76%
|
$721,243
244,489 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.29%
|
$273,499
92,691 shares
|
— | 30 Jun 2024 |
| MORGAN STANLEY |
13F
Company
|
0.24%
|
$232,153
78,696 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.23%
|
$214,840
72,827 shares
|
— | 30 Jun 2024 |
| Defender Capital, LLC. |
13F
Company
|
0.19%
|
$162,899
55,220 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
59,353
Rows loaded
1
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
2
Q3 2024 holders
1
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend